IP Library Granted Patent US 12,274,474
Granted Patent B2
US 12,274,474 · App. 18/123,819 · Granted Apr 15, 2025

Apparatuses for the implantation of medical devices and methods of use thereof

Inventors: Juan José Chacón Quirós (Alajuela, CR); Rudy A. Mazzocchi (Coral Springs, FL); Roberto De Mezerville (Alajuela, CR); John Hancock (Santa Barbara, CA); Nathalia Araujo (Alajuela, CR); Matthew Solar (Alajuela, CR); Nicholas Lewin (Alajuela, CR)
Assignee: Establishment Labs S.A.
A61B17/3468A61F2/0095A61F2/12A61M5/2053A61B2017/0023A61B2017/0042A61B2017/00544A61B2017/00548A61B2017/00792A61B2017/00796A61B2090/037A61F2250/0071A61F2250/009A61M2005/3128A61M2210/1007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,274,474
App. No.
18/123,819
Granted
Apr 15, 2025
Kind
B2
Abstract

A medical device may include a shaft extending between a proximal end and a distal end. The shaft may include a lumen therein. The medical device may include a handle coupled to the proximal end of the shaft and may include a mode selector. The mode selector may be adapted to transition between a first mode and a second mode of the medical device. The medical device may further include a compressed fluid source. In the first mode, the compressed fluid source may be fluidly coupled with the shaft so as to impart a negative pressure in at least a portion of the lumen. In the second mode, the compressed fluid source may be fluidly coupled with the shaft so as to impart a positive pressure in the at least a portion of the lumen.

Claims (29)

1. A medical device, comprising:

a shaft extending between a proximal end and a distal end, the shaft including a lumen therein;

a handle coupled to the proximal end of the shaft and including a mode selector, wherein the mode selector is adapted to transition between a first mode and a second mode of the medical device; and

a compressed fluid source fluidly coupled with the shaft;

wherein, in the first mode, the compressed fluid source is fluidly coupled with the shaft so as to impart a negative pressure in at least a portion of the lumen, and wherein in the second mode, the compressed fluid source is fluidly coupled with the shaft so as to impart a positive pressure in the at least a portion of the lumen.

2. The medical device of claim 1 , wherein the handle is detachably coupled with the shaft.

3. The medical device of claim 1 , wherein in the first mode the compressed fluid source is configured to draw an implant into the shaft.

4. The medical device of claim 1 , wherein the compressed fluid source includes a cartridge configured to contain a compressed fluid;

wherein the cartridge is coupled with the handle.

5. The medical device of claim 4 , wherein the cartridge is detachably coupled with the handle.

6. The medical device of claim 1 , wherein the handle defines a cavity;

wherein the compressed fluid source includes a cartridge positioned within the cavity and the cartridge is configured to contain a compressed fluid.

7. The medical device of claim 1 , wherein the mode selector includes a toggling switch.

8. The medical device of claim 1 , wherein the mode selector includes a trigger, the trigger configured to cause compressed gas to be applied to the shaft.

9. The medical device of claim 1 , including a valve mechanism fluidly interconnecting the compressed fluid source and the shaft.

10. The medical device of claim 1 , wherein the compressed fluid source includes a remote gas source positioned away from the handle; the medical device including:

a tubing assembly fluidly coupling the remote gas source with the handle, the tubing assembly having a suction line and a pressure line.

11. The medical device of claim 10 , wherein the handle includes a first half and a second half, the first half configured to receive the suction line and the second half configured to receive the pressure line.

12. The medical device of claim 1 , including a core seal at least partially received within the lumen of the shaft.

13. The medical device of claim 1 , including a core seal, a first O-ring and a second O-ring positioned between the shaft and the handle.

14. The medical device of claim 1 , including a nozzle removably coupled with the distal end of the shaft.

15. The medical device of claim 1 , including a nozzle coupled with the distal end of the shaft.

16. The medical device of claim 1 , including a flexible nozzle coupled with the distal end of the shaft.

17. The medical device of claim 1 , including a nozzle removably coupled with a distal portion of the shaft;

wherein the compressed fluid source is coupled with the distal portion of the shaft.

18. The medical device of claim 1 , wherein the mode selector is configured to toggle a valve mechanism to control a compressed fluid flow to the shaft to impart the positive pressure in the at least a portion of the lumen.

19. The medical device of claim 1 , wherein the mode selector is configured to toggle a valve mechanism to control a compressed fluid flow to the shaft to impart the negative pressure in the at least a portion of the lumen, the negative pressure configured to draw an implant into the lumen.

20. The medical device of claim 1 , including a negative pressure source in communication with the shaft and configured to draw a pre-filled breast implant into the shaft; and

a positive pressure source in communication with the shaft and configured to expel the pre-filled breast implant from the shaft, through a nozzle, and into a breast pocket of a subject.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2023
From: CHACON QUIROS, JUAN JOSE; MAZZOCCHI, RUDY A; DE MEZERVILLE, ROBERTO; HANCOCK, JOHN; ARAUJO, N ATHALIA; SOLAR, MATTHEW; LEWIN, NICHOLAS
To: ESTABLISHMENT LABS S.A.
Reel/Frame 063566/0681 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2023
From: CHACON QUIROS, JUAN JOSE; MAZZOCCHI, RUDY A; DE MEZERVILLE, ROBERTO; HANCOCK, JOHNATHAN; ARAUJO, NATHALIA; SOLAR, MATTHEW; LEWIN, NICHOLAS
To: ESTABLISHMENT LABS S.A.
Reel/Frame 063075/0238 →
Continuity (6)
Continuation 17733814 · Apr 29, 2022
Continuation 17128606 · Dec 21, 2020
Division 16092878
Provisional Application 62393970 · Sep 13, 2016
Provisional Application 62323160 · Apr 15, 2016
Related Publication 20230225761A1 · Jul 20, 2023
References Cited (114)
US 3815476A · Green et al. · 1974 [cited by applicant]
US 4102567A · Cuffe et al. · 1978 [cited by applicant]
US 4570626A · Norris et al. · 1986 [cited by applicant]
US 4955906A · Coggins et al. · 1990 [cited by applicant]
US 5500019A · Johnson · 1996 [cited by examiner]
US 5571178A · Ledergerber · 1996 [cited by applicant]
US 5800549A · Bao et al. · 1998 [cited by applicant]
US 5906574A · Kan · 1999 [cited by applicant]
US 6358197B1 · Silverman et al. · 2002 [cited by applicant]
US 8206443B2 · Preissman · 2012 [cited by examiner]
US 10398543B1 · Solar · 2019 [cited by applicant]
US 10905466B2 · Chacon Quiros · 2021 [cited by examiner]
US 11622791B2 · Chacón et al. · 2023 [cited by applicant]
US 11633546B2 · Olson et al. · 2023 [cited by applicant]
US 11883069B2 · Chacón et al. · 2024 [cited by applicant]
US 20020091299A1 · Silverman et al. · 2002 [cited by applicant]
US 20020136696A1 · Lee et al. · 2002 [cited by applicant]
US 20030004457A1 · Andersson · 2003 [cited by applicant]
US 20030049329A1 · Lee et al. · 2003 [cited by applicant]
US 20050049701A1 · Brennan · 2005 [cited by applicant]
US 20060224144A1 · Lee · 2006 [cited by applicant]
US 20090177165A1 · Tsao · 2009 [cited by applicant]
US 20090287190A1 · Shippert · 2009 [cited by applicant]
US 20120083768A1 · Skora · 2012 [cited by examiner]
US 20120143332A1 · Keller · 2012 [cited by examiner]
US 20120310332A1 · Murray · 2012 [cited by examiner]
US 20130304051A1 · Kimmel et al. · 2013 [cited by applicant]
US 20140200511A1 · Boyden · 2014 [cited by examiner]
US 20140257272A1 · Clark et al. · 2014 [cited by applicant]
US 20140303726A1 · Preissman · 2014 [cited by applicant]
US 20140358155A1 · Deboer et al. · 2014 [cited by applicant]
US 20150032208A1 · Preissman · 2015 [cited by examiner]
US 20160100958A1 · Behzadi · 2016 [cited by examiner]
US 20160310304A1 · Mialhe · 2016 [cited by examiner]
US 20180014900A1 · Vayser · 2018 [cited by examiner]
US 20190125401A1 · Chacon Quiros et al. · 2019 [cited by applicant]
US 20200046342A1 · Hess · 2020 [cited by examiner]
US 20200155313A1 · Zhang · 2020 [cited by examiner]
US 20200163543A1 · Schutt · 2020 [cited by examiner]
US 20210204976A1 · Chacón Quirós et al. · 2021 [cited by examiner]
US 20210338280A1 · Viquez et al. · 2021 [cited by applicant]
US 20220280190A1 · Viquez et al. · 2022 [cited by applicant]
US 20220323108A1 · Chacón Quirós et al. · 2022 [cited by applicant]
BR 1120180708500A2 · 2017 [cited by applicant]
BR 112018070850 · 2023 [cited by applicant]
CA 3020876A1 · 2017 [cited by applicant]
CN 2083935U · 1991 [cited by applicant]
CN 200951219Y · 2007 [cited by applicant]
CN 201551714U · 2010 [cited by applicant]
CN 102811754A · 2012 [cited by applicant]
CN 105105868A · 2015 [cited by applicant]
CN 109152640A · 2019 [cited by applicant]
CN 109152640B · 2021 [cited by applicant]
CN 113876399A · 2022 [cited by applicant]
EP 3442468A2 · 2019 [cited by applicant]
IL 262159 · 2018 [cited by applicant]
IL 294283 · 2022 [cited by applicant]
IL 262159B · 2022 [cited by applicant]
KR 20010000313A · 2001 [cited by applicant]
KR 20180137503A · 2018 [cited by applicant]
KR 102572735 · 2023 [cited by applicant]
WO WO2017181144A2 · 2017 [cited by applicant]
WO WO2017181144A3 · 2017 [cited by applicant]
WO WO2020070676A1 · 2020 [cited by applicant]
“U.S. Appl. No. 16/092,878, Notice of Allowability mailed Nov. 27, 2020”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/092,878, Notice of Allowability mailed Dec. 14, 2020”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/092,878, Notice of Allowance mailed Sep. 22, 2020”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/092,878, Notice of Allowance mailed Nov. 23, 2020”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 16/092,878, Preliminary Amendment filed Oct. 11, 2018”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/092,878, Response filed Aug. 18, 2020 to Restriction Requirement mailed Jun. 18, 2020”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/092,878, Restriction Requirement mailed Jun. 18, 2020”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/128,606, Preliminary Amendment filed Apr. 29, 2022”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 17/128,606, Preliminary Amendment filed Dec. 21, 2020”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/733,814, Non Final Office Action mailed Aug. 12, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/733,814, Notice of Allowance mailed Dec. 7, 2022”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 17/733,814, Preliminary Amendment filed Apr. 29, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/733,814, Response filed Nov. 11, 2022 to Non Final Office Action mailed Aug. 12, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/733,814, Supplemental Notice of Allowability mailed Dec. 21, 2022”, 2 pgs. [cited by applicant]
“Brazilian Application Serial No. 112018070850-0, Office Action mailed Jan. 6, 2022”, w/English Translation, 4 pgs. [cited by applicant]
“Brazilian Application Serial No. 112018070850-0, Opinion for non-patentability (RPI 7.1) mailed Feb. 15, 2023”, w/English Translation, 8 pgs. [cited by applicant]
“Brazilian Application Serial No. 112018070850-0, Response filed Apr. 19, 2022 to Office Action mailed Jan. 6, 2022”, w/English claims, 29 pgs. [cited by applicant]
“Chinese Application Serial No. 201780023175.6, Office Action mailed Feb. 25, 2020”, w/English translation, 10 pgs. [cited by applicant]
“Chinese Application Serial No. 201780023175.6, Office Action mailed Oct. 21, 2020”, w/English translation, 13 pgs. [cited by applicant]
“Chinese Application Serial No. 201780023175.6, Response filed Mar. 4, 2021 to Office Action mailed Oct. 21, 2020”, 3 pgs. [cited by applicant]
“Chinese Application Serial No. 201780023175.6, Response filed Jul. 10, 2020 to Office Action mailed Feb. 25, 2020”, 2 pgs. [cited by applicant]
“European Application Serial No. 17733113.9, Communication Pursuant to Article 94(3) EPC mailed Aug. 27, 2020”, 5 pgs. [cited by applicant]
“European Application Serial No. 17733113.9, Response filed Mar. 5, 2021 to Communication Pursuant to Article 94(3) EPC mailed Aug. 27, 2020”, 11 pgs. [cited by applicant]
“European Application Serial No. 17733113.9, Response to Communication pursuant to Rules 161(1) and 162 EPC filed Jun. 3, 2019”, 16 pgs. [cited by applicant]
“European Application Serial No. 22185151.2, Extended European Search Report mailed Oct. 27, 2022”, 8 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/027807, International Preliminary Report on Patentability mailed Oct. 25, 2018”, 10 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/027807, International Search Report mailed Oct. 10, 2017”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/027807, Written Opinion mailed Oct. 10, 2017”, 8 pgs. [cited by applicant]
“Israel Application Serial No. 262159, Notification Prior to Examination mailed Nov. 24, 2019”, 2 pgs. [cited by applicant]
“Israel Application Serial No. 262159, Office Action mailed Sep. 12, 2021”, 3 pgs. [cited by applicant]
“Israel Application Serial No. 262159, Office Action mailed Nov. 8, 2018”, 1 pg. [cited by applicant]
“Israel Application Serial No. 262159, Office Action mailed Dec. 28, 2021”, 3 pgs. [cited by applicant]
“Israel Application Serial No. 262159, Response filed Mar. 9, 2022 to Office Action mailed Dec. 28, 2021”, w/ English translation, 15 pgs. [cited by applicant]
“Israel Application Serial No. 262159, Response filed Mar. 15, 2020 to Notification Prior to Examination mailed Nov. 24, 2019”, w/ English translation, 11 pgs. [cited by applicant]
“Korean Application Serial No. 10-2018-7031668, Notice of Preliminary Rejection mailed Jul. 25, 2022”, w/ English translation, 38 pgs. [cited by applicant]
“Korean Application Serial No. 10-2018-7031668, Notice of Preliminary Rejection mailed Nov. 16, 2021”, w/ English translation, 12 pgs. [cited by applicant]
“Korean Application Serial No. 10-2018-7031668, Response filed Mar. 16, 2022 to Notice of Preliminary Rejection mailed Nov. 16, 2021”, (W/ English Translation), 35 pgs. [cited by applicant]
“Korean Application Serial No. 10-2018-7031668, Response filed Dec. 26, 2022 to Notice of Preliminary Rejection mailed Jul. 25, 2022”, w/ English claims, 20 pgs. [cited by applicant]
“U.S. Appl. No. 17/128,606, Non Final Office Action mailed May 4, 2023”, 8 pgs. [cited by applicant]
“Canadian Application Serial No. 3,020,876, Examiners Rule 86(2) Report mailed Jun. 7, 2023”, 4 pgs. [cited by applicant]
“Israeli Application Serial No. 302891, Notification Prior to Examination mailed May 14, 2023”, w English Claims, 5 pgs. [cited by applicant]
“Brazilian Application Serial No. 112018070850-0, Response filed Jun. 5, 2023 to Opinion for non-patenteability (RPI 7.1) mailed Feb. 15, 2023”, w English claims, 14 pgs. [cited by applicant]
“U.S. Appl. No. 17/128,606, Response filed Sep. 1, 2023 to Non Final Office Action mailed May 4, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/128,606, Notice of Allowance mailed Sep. 20, 2023”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 17/128,606, Supplemental Notice of Allowability mailed Sep. 28, 2023”, 3 pgs. [cited by applicant]
“Canadian Application Serial No. 3,020,876, Response filed Oct. 6, 2023 to Examiners Rule 86(2) Report mailed Jun. 7, 2023”, 12 pgs. [cited by applicant]
“Israeli Application Serial No. 302891, Notification of Defects in Patent Application mailed Aug. 22, 2023”, w English Claims, 6 pgs. [cited by applicant]
“U.S. Appl. No. 17/128,606, Supplemental Notice of Allowability mailed Dec. 21, 2023”, 2 pgs. [cited by applicant]
“Chinese Application Serial No. 202111068704.9, Office Action mailed Dec. 15, 2023”, w Machine English Translation, 8 pgs. [cited by applicant]
“Israeli Application Serial No. 302891, Response filed Jan. 22, 2024 to Notification of Defects in Patent Application mailed Aug. 22, 2023”, w current English claims, 9 pgs. [cited by applicant]